Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

77.07
Delayed Data
As of Nov 21
 -0.36 / -0.46%
Today’s Change
62.88
Today|||52-Week Range
100.13
-9.49%
Year-to-Date
2 Beaten-Down Biotech Stocks That Could Make You Rich
Nov 11 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close77.43
Today’s open77.28
Day’s range76.21 - 77.36
Volume1,745,132
Average volume (3 months)1,356,650
Market cap$13.5B
Data as of 4:00pm ET, 11/21/2019

Growth & Valuation

Earnings growth (last year)+34.91%
Earnings growth (this year)+38.96%
Earnings growth (next 5 years)+52.10%
Revenue growth (last year)+13.51%
P/E ratioNM
Price/Sales10.07
Price/Book4.51

Competitors

 Today’s
change
Today’s
% change
EXASExact Sciences Corp-4.91-5.85%
NBIXNeurocrine Bioscienc...+0.67+0.59%
TECHBio-Techne Corp-3.44-1.58%
MRNAModerna Inc+0.02+0.10%
Data as of 4:00pm ET, 11/21/2019

Financials

Next reporting dateFebruary 24, 2020
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.5B
Annual profit (last year)-$77.2M
Net profit margin-5.16%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Rafael, California

Forecasts